scholarly article | Q13442814 |
P50 | author | Baris Turkbey | Q88769455 |
Peter L Choyke | Q90059714 | ||
Peter A Pinto | Q90059716 | ||
Howard L Parnes | Q93104466 | ||
Arvin K George | Q96240193 | ||
Maria J Merino | Q107749611 | ||
Mohummad Minhaj Siddiqui | Q37831177 | ||
Soroush Rais-Bahrami | Q40114897 | ||
Bradford J. Wood | Q40114938 | ||
P2093 | author name string | Rachel Rubin | |
Richard M Simon | |||
P2860 | cites work | ESUR prostate MR guidelines 2012 | Q24620926 |
Systematic review of complications of prostate biopsy | Q26822966 | ||
Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. | Q30650693 | ||
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. | Q30664726 | ||
Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy. | Q36386904 | ||
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer | Q37254919 | ||
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen | Q37381526 | ||
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review | Q38278155 | ||
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer | Q40114843 | ||
Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer | Q40199490 | ||
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. | Q45967722 | ||
Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. | Q46326701 | ||
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate Biopsies | Q56688802 | ||
Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy | Q63966461 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cancer diagnosis | Q110324059 |
prostate cancer | Q181257 | ||
biopsy | Q179991 | ||
P577 | publication date | 2016-04-29 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions. | |
P478 | volume | 108 |
Q92732671 | Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction |
Q39446394 | Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlation |
Q38376726 | Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy |
Q42366596 | DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy |
Q58562192 | Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies |
Q52887561 | Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations. |
Q93177852 | Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy |
Q95261579 | Evolution of prostate cancer diagnosis: retrospective analysis of magnetic resonance imaging/ultrasound fusion guided biopsies protocol in routine practice and patients management |
Q38989771 | Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population |
Q93025020 | Financial implications of biparametric prostate MRI |
Q38808867 | Focal Therapy for Prostate Cancer: Pending Questions |
Q60923446 | Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification |
Q90257493 | Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns |
Q92090246 | Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions |
Q58562086 | MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence |
Q52624219 | MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? |
Q55421492 | MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men. |
Q38377827 | Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy |
Q47252469 | Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy |
Q42374568 | Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer |
Q39151621 | Pathological Findings in Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy: Relation to Prostate Cancer Focal Therapy |
Q58801432 | Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets |
Q89396666 | Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? |
Q38843182 | Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers |
Q48159238 | Role of systematic biopsy in the era of multiparametric magnetic resonance imaging and ultrasound fusion guidance |
Q47588633 | Ruling out clinically significant prostate cancer with negative multi-parametric MRI. |
Q57109743 | Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy |
Q57107312 | The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime? |
Q38950693 | The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy. |
Q90428558 | Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications |
Search more.